STAAR Surgical board urges shareholders to approve Alcon merger
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
October 8, 2025 11:40 AM EDTComments on Glass Lewis Report
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA) (STAAR), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC (Glass Lewis) related to STAARs pending merger with Alcon (SIX/NYSE: ALC):
The STAAR Board of Directors and management team strongly disagree with the recommendation issued by Glass Lewis. Alcon is... More



